Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)
Clinical trial NCT04480424 · COMPLETED
Trial details
- NCT number
- NCT04480424
- Sponsor
- Grifols Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-17
- Primary completion
- 2021-08-25
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.